ALEVE NIGHTTIME

Bayer Inc🇨🇦 Health Canada

Approval Id: 5fd2ca78b4b1de8f
Drug Approval Canada Name: ALEVE NIGHTTIME
Product Name: ALEVE NIGHTTIME
Status: Marketed
Status Date: 2016-02-24
Original Market Date: 2016-02-24
Din: 02444593
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: OTC
Ahfs: 28:08.04.92
Atc Original: M01AE02 NAPROXEN
Atc Name: m 01 ae 02
Aig Number: 0257270001
Company Name: Bayer Inc
Company Address: 2920 Matheson Blvd East, Mississauga, Ontario, Canada, L4W 5R6

NAPROXEN SODIUM

220 MG

DIPHENHYDRAMINE HYDROCHLORIDE

25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5fd2ca78b4b1de8f

Type

Standard